John I. Risinger
Papers
1
Total Citations
2
H-Index
1
About
John I. Risinger is a leading researcher in gynecologic oncology, with a specialized focus on the molecular underpinnings and clinical management of uterine serous carcinoma and other high-risk endometrial cancers. His work bridges the critical gap between genomic discoveries and patient care, particularly in refining diagnostic and staging protocols. A hallmark contribution is his investigation into the ambiguous role of peritoneal washings in endometrial cancer staging. Through detailed case analyses, such as his 2022 study of a patient with non-myoinvasive uterine serous carcinoma confined to a polyp and positive peritoneal washings, he has highlighted the pressing need for standardized clinical guidelines. This work, which identified somatic *ARHGAP35* and *KRAS* mutations, underscores his commitment to integrating molecular profiling with surgical pathology to improve prognostic accuracy. While his most cited paper currently holds 2 citations, its impact lies in its timely challenge to existing clinical paradigms, prompting further research into the significance of peritoneal cytology. Risinger’s research is essential reading for clinicians and scientists seeking to understand the complexities of endometrial cancer staging and the personalized application of genomic data.
Research Focus
Key Achievements
Top Papers
- 1